| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/14/2013 | US20130039940 Homogenous Vaccine Composition Comprising a Conjugate of EGF and P64K for the Treatment of Tumors |
| 02/14/2013 | US20130039939 Lipopeptide- and lipoprotein-conjugates and its use |
| 02/14/2013 | US20130039938 Highly efficient influenza matrix (m1) proteins |
| 02/14/2013 | US20130039937 Peptide Sequences and Compositions |
| 02/14/2013 | US20130039936 Immunogenic pote peptides and methods of use |
| 02/14/2013 | US20130039935 Induction of tumor immunity by variants of folate binding protein |
| 02/14/2013 | US20130039934 Treatment of ige-mediated disease |
| 02/14/2013 | US20130039933 Sting (stimulator of interferon genes), a regulator of innate immune responses |
| 02/14/2013 | US20130039931 Antibodies Against A Cancer-Associated Epitope of Variant HNRNPG and Uses Thereof |
| 02/14/2013 | US20130039930 Biomarker for sensitivity to therapy with a notch inhibitor |
| 02/14/2013 | US20130039929 Method treating breast cancer |
| 02/14/2013 | US20130039928 Compositions and methods for reversing corticosteroid resistance or treating respiratory infections |
| 02/14/2013 | US20130039927 Antigenic mimics of discontinuous epitopes of pathogen recognized by broadly neutralizing antibodies |
| 02/14/2013 | US20130039926 Human antibodies against rabies and uses thereof |
| 02/14/2013 | US20130039925 Alternative pathway specific antibodies for treating arthritis |
| 02/14/2013 | US20130039924 Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases |
| 02/14/2013 | US20130039923 Anti-human interleukin-20 antibodies |
| 02/14/2013 | US20130039922 Antibodies that inhibit metalloproteins |
| 02/14/2013 | US20130039921 Treatment of Inflammatory Skin Disease and Psychiatric Conditions |
| 02/14/2013 | US20130039920 Specific binding proteins and uses thereof |
| 02/14/2013 | US20130039919 Novel plasminogen receptor, polypeptides and antibodies thereof |
| 02/14/2013 | US20130039918 Pharmaceutical Composition Using Connective-tissue Growth Factor |
| 02/14/2013 | US20130039917 Diagnostic and therapeutic target |
| 02/14/2013 | US20130039916 ENGINEERED ANTI-IL-23p19 ANTIBODIES |
| 02/14/2013 | US20130039915 Siglec 15 antibodies in treating bone loss-related disease |
| 02/14/2013 | US20130039914 Novel human genes relating to respiratory diseases and obesity |
| 02/14/2013 | US20130039913 Heterodimeric antibody fc-containing proteins and methods for production thereof |
| 02/14/2013 | US20130039912 Robo1-fc fusion protein and use thereof for treating tumours |
| 02/14/2013 | US20130039911 Compositions and Methods for Targeted Immunomodulatory Antibodies and Fusion Proteins |
| 02/14/2013 | US20130039910 Methods and compositions for modulating angiogenesis and pericyte composition |
| 02/14/2013 | US20130039909 Predicting response to a her inhibitor |
| 02/14/2013 | US20130039908 Prognostic markers and methods for prostate cancer |
| 02/14/2013 | US20130039907 Methods of treating hematological proliferative disorders by targeting epha3 expressed on aberrant vasculature in bone marrow |
| 02/14/2013 | US20130039906 PYRAZOLO[3,4-c]PYRIDINE COMPOUNDS AND METHODS OF USE |
| 02/14/2013 | US20130039905 Diazoxide For Use In The Treatment Or Prevention Of A Central Nervous System (CNS) Autoimmune Demyelinating Disease |
| 02/14/2013 | US20130039904 Gambogic acid cyclization analogues, their preparation method and application thereof |
| 02/14/2013 | US20130039903 Eczema treatment |
| 02/14/2013 | US20130039886 Beta-mannosylceramide and stimulation of nkt cell anti-tumor immunity |
| 02/14/2013 | US20130039885 Leukotoxin e/d as a new anti-inflammatory agent and microbicide |
| 02/14/2013 | US20130039884 Compositions and methods for improving production of recombinant polypeptides |
| 02/14/2013 | US20130039883 Method of sensitizing cancer cells to the cytotoxic effects of death receptor ligands in cancer treatment |
| 02/14/2013 | US20130039857 Methods of suppressing cancer, increasing weight loss and/or increasing insulin sensitivity |
| 02/14/2013 | US20130039856 Products and Methods |
| 02/14/2013 | US20130039852 Methods of targeting cells for diagnosis and therapy |
| 02/14/2013 | US20130039851 Stabilizing Alkylglycoside Compositions and Methods Thereof |
| 02/14/2013 | US20130039850 Heterologous antibodies which bind human cd4 |
| 02/14/2013 | US20130039849 Adenocarcinoma specific antibody sam-6, and uses thereof |
| 02/14/2013 | US20130039848 Fluorescent silica-based nanoparticles |
| 02/14/2013 | CA2844668A1 Methods and compositions for the treatment of autoimmune and inflammatory diseases |
| 02/14/2013 | CA2844662A1 Methods of treating progressive forms of multiple sclerosis |
| 02/14/2013 | CA2844435A1 Highly galactosylated antibodies |
| 02/14/2013 | CA2844283A1 Methods and compositions relating to p62 for the treatment and prophylaxis of cancer |
| 02/14/2013 | CA2843960A1 Antibodies binding to phosphorylcholine (pc) and/or pc conjugates |
| 02/14/2013 | CA2843921A1 New antibodies against phosphorylcholine |
| 02/14/2013 | CA2842971A1 Improved methods and compositions for modulation of olfml3 mediated angiogenesis |
| 02/14/2013 | CA2841874A1 Methods and compositions for modulating voltage-gated calcium channel function |
| 02/13/2013 | EP2557164A1 Induced activation in dendritic cells |
| 02/13/2013 | EP2557159A1 Prognostic method for pulmonary adenocarcinoma, pulmonary adenocarcinoma detection kit, and pharmaceutical composition for treating pulmonary adenocarcinoma |
| 02/13/2013 | EP2557155A1 Metal salen complex derivative and process for production thereof |
| 02/13/2013 | EP2557090A2 Amino acid sequences directed against GPCRs and polypeptides comprising the same for the treatment of GPCR-related diseases and disorders |
| 02/13/2013 | EP2556841A1 Method for inhibiting bone resorption |
| 02/13/2013 | EP2556379A1 New diagnostic and therapeutic target |
| 02/13/2013 | EP2556161A1 Methods for the treatment of autoimmune diseases |
| 02/13/2013 | EP2556086A1 Btnl9 proteins, nucleic acids, and antibodies and uses thereof |
| 02/13/2013 | EP2555798A1 Methods and compositions for inhibiting hiv transmission |
| 02/13/2013 | EP2555797A1 Tnf- binding proteins |
| 02/13/2013 | EP2555796A1 Immune modulation |
| 02/13/2013 | EP2555795A1 Recombinant multimeric influenza proteins |
| 02/13/2013 | EP2555794A1 COMPOSITIONS AND METHODS RELATED TO PROTEIN A (SpA) ANTIBODIES AS AN ENHANCER OF IMMUNE RESPONSE |
| 02/13/2013 | EP2555753A2 Vehicle for delivering a compound to a mucous membrane and related compositions, methods and systems |
| 02/13/2013 | EP2555627A1 Methods of treating cancer |
| 02/13/2013 | EP2479270A9 Gene expressing a bifidobacterium surface-presented fusion protein |
| 02/13/2013 | CN102933603A Methods for treating pancreatic cancer |
| 02/13/2013 | CN102933602A Antibodies to human GDF8 |
| 02/13/2013 | CN102933597A Antigenic polypeptides of trichinella and uses thereof |
| 02/13/2013 | CN102933232A Immunogen adherence and method of making and using same |
| 02/13/2013 | CN102933231A Cd20 antibodies and uses thereof |
| 02/13/2013 | CN102933230A Methods and compositions for intranasal delivery |
| 02/13/2013 | CN102933229A Vaccine formulations |
| 02/13/2013 | CN102933228A System and method of preparing and storing activated mature dendritic cells |
| 02/13/2013 | CN102925486A Porcine circovirus type 2 subunit vaccine, and preparation method and application thereof |
| 02/13/2013 | CN102925476A Preparation method and application of self-combined immunogenic enterovirus-like particles in yeast |
| 02/13/2013 | CN102925414A Swine Japanese encephalitis virus strain and application thereof |
| 02/13/2013 | CN102924600A Death receptor-5 agitated polyvalent antibody and application thereof in preparation of anti-tumor medicines |
| 02/13/2013 | CN102924599A Antibody, as well as application and preparation method thereof |
| 02/13/2013 | CN102924598A Anti-alphavbeta6 antibodies |
| 02/13/2013 | CN102924596A Anti-il-6 antibodies, compositions, methods and uses |
| 02/13/2013 | CN102924576A Helicobacter pylori immunodominance epitope peptide and preparation method and application thereof |
| 02/13/2013 | CN102924571A Rabies virus glycoprotein and nucleoprotein antigen epitope polypeptides, and screening and identification method and application thereof |
| 02/13/2013 | CN102921020A Gene drug for combined treatment on tumors, and use thereof |
| 02/13/2013 | CN102921007A Method and reagent used for controlling insulin resistance and diabetes mellitus |
| 02/13/2013 | CN102921004A Immunoglobulin g (igg) concentrate depleted of anti-a and anti-b antibodies and of polyreactive iggs |
| 02/13/2013 | CN102921003A Stabilized immune modulatory RNA (SIMRA) compounds |
| 02/13/2013 | CN102921002A Japanese encephalitis vaccine cryoprotectant |
| 02/13/2013 | CN102920996A Impaired wound healing compositions and treatments |
| 02/13/2013 | CN102919850A Composition for nutritional food and drugs |
| 02/13/2013 | CN102352365B Method for clearing away mycoplasma from pseudorabies vaccine strains |
| 02/13/2013 | CN102344914B Construction and application of recombinant MDV (Marek's Disease Virus) strain for expressing REV env (Reticuloendotheliosis Viruses envelope) |
| 02/13/2013 | CN102343088B Canine infectious tracheobronchitis bivalent live vaccine and preparation method thereof |
| 02/13/2013 | CN102319431B Monoclonal antibody for detecting and treating senile dementia |